Baxter International | BAX - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Abbott USD 52.06B 69M 2026-03
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 450.47M 2.24M 2026-03
AtriCure USD 516.43M 24.74M 2026-06
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Fresenius EUR 19.7B 766M 2026-06
Globus Medical USD 4.77B 36.29M 2026-06
Halozyme Therapeutics USD 143.54M 76.09M 2026-06
ICU Medical USD 2.15B 39.92M 2026-06
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.42B 119.6M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 18.17B 693.9M 2026-06
J&J USD 84.97B 3.78B 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.68B 53.08M 2026-06
Quest Diagnostics USD 7.52B 150M 2026-06
Smith & Nephew USD 5.18B 356M 2026-06
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Terumo JPY 1.66T 77.51B 2026-06
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06